TY - JOUR
T1 - Biofabrication of Self-Assembling Covalent Protein Nanoparticles through Histidine-Templated Cysteine Coupling
AU - López-Laguna, Hèctor
AU - Rueda, Ariana
AU - Martínez-Torró, Carlos
AU - Sánchez-Alba, Lucía
AU - Carratalá, José Vicente
AU - Atienza-Garriga, Jan
AU - Parladé, Eloi
AU - Sánchez, Julieta M.
AU - Serna, Naroa
AU - Voltà-Durán, Eric
AU - Ferrer-Miralles, Neus
AU - Reverter, David
AU - Mangues, Ramon
AU - Villaverde, Antonio
AU - Vázquez, Esther
AU - Unzueta, Ugutz
N1 - Funding Information:
The authors are indebted to Agencia Estatal de Investigación (PID2020-116174RB-I00) granted to A.V.; to ISCIII (PI20/00400) cofunded by the European Regional Development Fund (ERDF, a way to make Europe) and to CIBER-BBN (project NANOSCAPE and NANOLINK) granted to U.U.; to AEI (PID2019-105416RB-I00/AEI/10.13039/501100011033) and to CIBER-BBN (NANOREMOTE) granted to E.V.; to AEI (PID2019-107298RB-C22) granted to N.F.-M.; to Ministerio de Ciencia, Innovación y Universidades (PGC2018-098423-B-I00) granted to D.R.; and to ISCIII (PI21/00150), cofunded by the European Regional Development Fund (ERDF, a way to make Europe), to CIBER-BBN (4NanoMets), and to AGAUR (2017 SGR-865) granted to R.M. This research was also supported by CIBER-Consorcio Centro de Investigación Biomédica en Red- (CB06/01/1031 and CB06/01/0014), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and European Regional Development Fund (ERDF) and by the CERCA program (Generalitat de Catalunya). U.U. is supported by a Miguel Servet contract (CP19/00028) from ISCIII cofunded by the European Social Fund (ESF investing in your future). H.L.-L. received a predoctoral fellowship from AGAUR (2019 FI_B 00352). J.M.S. is supported by a María Zambrano researcher contract (677904) from Ministerio de Universidades. A.R. was supported by a PFIS predoctoral fellowship (FI21/00012) from ISCIII cofunded by the European Social Fund (ESF, investing in your future). L.S.-A. was supported by a predoctoral fellowship from the Ministerio de Ciencia, Innovación y Universidades (FPI18/04615). E.V.-D. was supported by a predoctoral fellowship from the Ministerio de Ciencia, Innovación y Universidades (FPU18/04615). J.A.-G. was supported by a predoctoral fellowship from the Ministerio de Universidades (FPU20/02260). A.V. received an Icrea Academia award. Protein production was partially performed by the ICTS “NANBIOSIS”, more specifically by the Protein Production Platform of CIBER in Bioengineering, Biomaterials & Nanomedicine (CIBER-BBN)/IBB, at the UAB http://www.nanbiosis.es/portfolio/u1-protein-production-platform-ppp/. Molecular graphics were performed with UCSF ChimeraX, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from the National Institutes of Health R01-GM129325 and the Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases. We are also indebted to Servei de Microscòpia and Servei de Cultius Cel·lulars, Anticossos i Citometria (SCAC) from UAB for their excellent services and technical support.
Funding Information:
The authors are indebted to Agencia Estatal de Investigación (PID2020-116174RB-I00) granted to A.V.; to ISCIII (PI20/00400) cofunded by the European Regional Development Fund (ERDF, a way to make Europe) and to CIBER-BBN (project NANOSCAPE and NANOLINK) granted to U.U.; to AEI (PID2019-105416RB-I00/AEI/10.13039/501100011033) and to CIBER-BBN (NANOREMOTE) granted to E.V.; to AEI (PID2019-107298RB-C22) granted to N.F.-M.; to Ministerio de Ciencia, Innovación y Universidades (PGC2018-098423-B-I00) granted to D.R.; and to ISCIII (PI21/00150), cofunded by the European Regional Development Fund (ERDF, a way to make Europe), to CIBER-BBN (4NanoMets), and to AGAUR (2017 SGR-865) granted to R.M. This research was also supported by CIBER-Consorcio Centro de Investigación Biomédica en Red- (CB06/01/1031 and CB06/01/0014), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and European Regional Development Fund (ERDF) and by the CERCA program (Generalitat de Catalunya). U.U. is supported by a Miguel Servet contract (CP19/00028) from ISCIII cofunded by the European Social Fund (ESF investing in your future). H.L.-L. received a predoctoral fellowship from AGAUR (2019 FI_B 00352). J.M.S. is supported by a María Zambrano researcher contract (677904) from Ministerio de Universidades. A.R. was supported by a PFIS predoctoral fellowship (FI21/00012) from ISCIII cofunded by the European Social Fund (ESF, investing in your future). L.S.-A. was supported by a predoctoral fellowship from the Ministerio de Ciencia, Innovación y Universidades (FPI18/04615). E.V.-D. was supported by a predoctoral fellowship from the Ministerio de Ciencia, Innovación y Universidades (FPU18/04615). J.A.-G. was supported by a predoctoral fellowship from the Ministerio de Universidades (FPU20/02260). A.V. received an Icrea Academia award. Protein production was partially performed by the ICTS “NANBIOSIS”, more specifically by the Protein Production Platform of CIBER in Bioengineering, Biomaterials & Nanomedicine (CIBER-BBN)/IBB, at the UAB http://www.nanbiosis.es/portfolio/u1-protein-production-platform-ppp/ . Molecular graphics were performed with UCSF ChimeraX, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from the National Institutes of Health R01-GM129325 and the Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases. We are also indebted to Servei de Microscòpia and Servei de Cultius Cel·lulars, Anticossos i Citometria (SCAC) from UAB for their excellent services and technical support.
Publisher Copyright:
© 2023 American Chemical Society
PY - 2023/3/13
Y1 - 2023/3/13
N2 - Nanoscale protein materials show increasing applications in biotechnology and biomedicine, addressing catalysis, drug delivery, or tissue engineering. Although protein oligomerization is reachable through several engineering approaches, including the use of divalent cations for histidine-rich stretches, the effectiveness of cation-His binding is influenced by protein conformation, media composition, and chelating agents. Thus, looking for powerful, green, cross-linker-free, and transversal oligomerization platforms, we have built a histidine-templated cysteine-coupling concept. On this basis, we have engineered a Cys-containing, H6-derived His-Cys hybrid tag that enables the spontaneous and efficient self-assembling of tagged proteins into monodisperse nanoparticles through a highly ordered covalent binding process. Although the generated nanostructures are supported by disulfide bridge formation and exclusively reversed by reducing agents but not by chelating agents, the presence of cysteine residues does not disrupt the metal-binding abilities of histidine residues within the tag. This fact allows one to combine the one-step IMAC-based protein purification and, also, the Zn2+-induced formation of higher-order microparticulate materials as nanoparticle-releasing protein-only depots. The dual mode of cross-molecular interactivity shown by the hybrid tag and the structural robustness and stability of the resulting nanoparticles offer wide applicability of the green biofabrication concept proposed here for the further development of clinically usable protein materials.
AB - Nanoscale protein materials show increasing applications in biotechnology and biomedicine, addressing catalysis, drug delivery, or tissue engineering. Although protein oligomerization is reachable through several engineering approaches, including the use of divalent cations for histidine-rich stretches, the effectiveness of cation-His binding is influenced by protein conformation, media composition, and chelating agents. Thus, looking for powerful, green, cross-linker-free, and transversal oligomerization platforms, we have built a histidine-templated cysteine-coupling concept. On this basis, we have engineered a Cys-containing, H6-derived His-Cys hybrid tag that enables the spontaneous and efficient self-assembling of tagged proteins into monodisperse nanoparticles through a highly ordered covalent binding process. Although the generated nanostructures are supported by disulfide bridge formation and exclusively reversed by reducing agents but not by chelating agents, the presence of cysteine residues does not disrupt the metal-binding abilities of histidine residues within the tag. This fact allows one to combine the one-step IMAC-based protein purification and, also, the Zn2+-induced formation of higher-order microparticulate materials as nanoparticle-releasing protein-only depots. The dual mode of cross-molecular interactivity shown by the hybrid tag and the structural robustness and stability of the resulting nanoparticles offer wide applicability of the green biofabrication concept proposed here for the further development of clinically usable protein materials.
KW - Biofabrication
KW - Covalent binding
KW - Linker-free
KW - Protein engineering
KW - Protein nanomaterials
KW - Self-assembling
UR - http://www.scopus.com/inward/record.url?scp=85147231187&partnerID=8YFLogxK
U2 - 10.1021/acssuschemeng.2c06635
DO - 10.1021/acssuschemeng.2c06635
M3 - Article
AN - SCOPUS:85147231187
SN - 2168-0485
VL - 11
SP - 4133
EP - 4144
JO - ACS Sustainable Chemistry and Engineering
JF - ACS Sustainable Chemistry and Engineering
IS - 10
ER -